Evidence map›Paper›PMID 34864913›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Reply to Caldwell et al.

Michael J Satlin, Liang Chen, Claire Douglass, Michael Hovan, Emily Davidson, Rosemary Soave, Marisa La Spina, Alexandra Gomez-Arteaga, Koen van Besien, Sebastian Mayer and 8 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Michael J SatlinTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Liang ChenCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Claire DouglassNewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, USA.
Michael HovanNewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, USA.
Emily DavidsonCooper Medical School of Rowan University, Camden, New Jersey, USA.
Rosemary SoaveTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Marisa La SpinaNewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, USA.
Alexandra Gomez-ArteagaDepartment of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USAand.
Koen van BesienDepartment of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USAand.
Sebastian MayerDepartment of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USAand.
Adrienne PhillipsDepartment of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USAand.
Jing Mei HsuDepartment of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USAand.
Rianna MalherbeHardy Diagnostics, Santa Maria, California, USA.
Catherine B SmallTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Stephen G JenkinsTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Lars F WestbladeTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Barry N KreiswirthCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Thomas J WalshTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Funding

The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
Predicting Infections in Neutropenic Hosts Receiving Fluoroquinolone ProphylaxisR03AI146612 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SATLIN, MICHAEL JOSEPH · 2020 to 2021
$170k
National Institute of Allergy and Infectious DiseasesNIAID NIH HHS R01 AI090155NIH HHS R03 AI146612
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34864913
PMCPMC9402634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.